RetinalGenix Technologies Inc. (RTGN)

RetinalGenix Technologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.01	0.01	-	0	0
Cash & Short-Term Investments	0.01	0.01	-	0	0
Cash Growth	143.80%	-	-	-99.23%	122.94%
Total Current Assets	0.01	0.01	-	0	0
Property, Plant & Equipment	0	0.01	0	0	-
Other Long-Term Assets	0	0	-	-	-
Total Assets	0.02	0.01	0	0	0
Accounts Payable	1.08	0.92	0.88	0.48	0.25
Accrued Expenses	0.02	0.02	0.01	0.01	0
Short-Term Debt	0.54	0.52	0.51	0.16	0.07
Current Portion of Leases	0	0	-	-	-
Other Current Liabilities	0.67	0.02	0	0.43	0.14
Total Current Liabilities	2.32	1.47	1.41	1.07	0.47
Long-Term Leases	0	0.01	-	-	-
Total Liabilities	2.32	1.48	1.41	1.07	0.47
Common Stock	0	0	0	0	0
Additional Paid-In Capital	15.68	14.12	9.7	7.95	4.64
Retained Earnings	-17.86	-15.43	-11.11	-9.02	-5.1
Comprehensive Income & Other	-0.13	-0.15	-	-	-
Total Common Equity	-2.3	-1.46	-1.41	-1.07	-0.46
Shareholders' Equity	-2.3	-1.46	-1.41	-1.07	-0.46
Total Liabilities & Equity	0.02	0.01	0	0	0
Total Debt	0.54	0.52	0.51	0.16	0.07
Net Cash (Debt)	-0.53	-0.52	-0.51	-0.16	-0.07
Net Cash Per Share	-0.03	-0.03	-0.03	-0.01	-0.00
Filing Date Shares Outstanding	18.75	18.52	17.79	17.27	14.28
Total Common Shares Outstanding	18.75	18.52	17.64	17.27	14.22
Working Capital	-2.31	-1.46	-1.41	-1.07	-0.46
Book Value Per Share	-0.12	-0.08	-0.08	-0.06	-0.03
Tangible Book Value	-2.3	-1.46	-1.41	-1.07	-0.46
Tangible Book Value Per Share	-0.12	-0.08	-0.08	-0.06	-0.03
Machinery	-	0	0	0	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.